Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2025 Financial Results on July 31, 2025
Balchem Corporation (NASDAQ: BCPC) has scheduled its second quarter 2025 financial results conference call for July 31, 2025, at 11:00 AM Eastern Time. The company's Chairman, President and CEO Ted Harris, along with CFO Martin Bengtsson, will host the call.
The Q2 2025 results will be released before market opening on the same day and will be available on www.balchem.com. Institutional investors and analysts can join by dialing 800-715-9871 (USA/Canada toll-free). A live webcast and replay will be accessible at the company's investor events portal.
Balchem Corporation (NASDAQ: BCPC) ha programmato la conference call per la presentazione dei risultati finanziari del secondo trimestre 2025 il 31 luglio 2025 alle 11:00 ora Eastern. La chiamata sarà condotta dal Presidente, CEO Ted Harris, insieme al CFO Martin Bengtsson.
I risultati del Q2 2025 saranno pubblicati prima dell'apertura dei mercati nello stesso giorno e saranno disponibili su www.balchem.com. Investitori istituzionali e analisti potranno partecipare chiamando il numero 800-715-9871 (numero verde USA/Canada). Saranno inoltre disponibili una diretta streaming e la registrazione sul portale degli eventi per gli investitori della società.
Balchem Corporation (NASDAQ: BCPC) ha programado su conferencia telefónica para los resultados financieros del segundo trimestre de 2025 el 31 de julio de 2025 a las 11:00 AM hora del Este. La llamada será dirigida por el Presidente, CEO Ted Harris, junto con el CFO Martin Bengtsson.
Los resultados del Q2 2025 se publicarán antes de la apertura del mercado ese mismo día y estarán disponibles en www.balchem.com. Los inversores institucionales y analistas podrán unirse llamando al 800-715-9871 (línea gratuita en EE.UU. y Canadá). También habrá una transmisión en vivo y repetición accesible en el portal de eventos para inversores de la empresa.
Balchem Corporation (NASDAQ: BCPC)은 2025년 2분기 재무 실적 컨퍼런스 콜을 2025년 7월 31일 오전 11시(동부 시간)에 예정하고 있습니다. 회사의 회장 겸 사장 겸 CEO인 Ted Harris와 CFO Martin Bengtsson이 콜을 주최합니다.
2025년 2분기 실적은 같은 날 시장 개장 전에 발표되며 www.balchem.com에서 확인할 수 있습니다. 기관 투자자와 애널리스트는 800-715-9871 (미국/캐나다 무료 전화)로 참여할 수 있습니다. 회사의 투자자 이벤트 포털에서 라이브 웹캐스트 및 재방송도 이용 가능합니다.
Balchem Corporation (NASDAQ : BCPC) a programmé sa conférence téléphonique sur les résultats financiers du deuxième trimestre 2025 pour le 31 juillet 2025 à 11h00, heure de l'Est. Le président, président-directeur général Ted Harris, accompagné du directeur financier Martin Bengtsson, animera l'appel.
Les résultats du T2 2025 seront publiés avant l'ouverture des marchés le même jour et seront disponibles sur www.balchem.com. Les investisseurs institutionnels et les analystes pourront participer en composant le 800-715-9871 (numéro gratuit aux États-Unis et au Canada). Une webdiffusion en direct et un replay seront accessibles sur le portail des événements investisseurs de la société.
Balchem Corporation (NASDAQ: BCPC) hat seine Telefonkonferenz zu den Finanzergebnissen des zweiten Quartals 2025 für den 31. Juli 2025 um 11:00 Uhr Eastern Time angesetzt. Der Vorstandsvorsitzende, Präsident und CEO Ted Harris sowie CFO Martin Bengtsson werden die Konferenz leiten.
Die Ergebnisse des Q2 2025 werden am selben Tag vor Börsenöffnung veröffentlicht und sind unter www.balchem.com verfügbar. Institutionelle Investoren und Analysten können sich unter der gebührenfreien Nummer 800-715-9871 (USA/Kanada) einwählen. Ein Live-Webcast und eine Wiederholung sind im Investor-Event-Portal des Unternehmens zugänglich.
- None.
- None.
MONTVALE, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, July 31, 2025, at 11:00 AM Eastern Time (ET) to review second quarter 2025 results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call.
Second quarter results will be published prior to the market opening on Thursday, July 31, 2025. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call.
To improve the quality of both the live and recorded audio for our conference calls, we have changed systems so please take note of the new procedures.
Institutional investors, analysts and other members of the financial community are invited to join the live call by dialing 800-715-9871 (toll free USA/Canada), +1-646-307-1963 (USA/International) or 647-932-3411 (Canada/Toronto), five minutes prior to the scheduled start time of the conference call. Investors and the public are invited to listen to the live webcast at https://events.q4inc.com/attendee/126702503. The conference call will be available for replay shortly after the conclusion of the call at https://events.q4inc.com/attendee/126702503 for one year.
About Balchem Corporation
Balchem Corporation develops, manufactures, and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement, and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
| Contact: | Jacqueline Yarmolowicz, Executive Assistant |
| Telephone: 845-326-5600 E-mail: jyarmolowicz@balchem.com | |
FAQ
When will Balchem (NASDAQ:BCPC) report Q2 2025 earnings?
How can investors access Balchem's Q2 2025 earnings call?
Who will host Balchem's Q2 2025 earnings conference call?
Where can I find Balchem's Q2 2025 earnings press release?
